Trading-Stocks.de

Healthcare | Medical Appliances & Equipment | USA
Boston Scientific (BSX) Q4 Earnings and Revenues Beat Estimates

Boston Scientific (BSX) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.34 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 5.41%. A quarter ago, it was expected that this medical device manufacturer would post earnings of $0.34 per share when it actually produced earnings of $0.35, delivering a surprise of 2.94%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Boston Scientific, which belongs to the Zacks Medical - Products industry, posted revenues of $2.56 billion for the quarter ended December 2018, surpassing the Zacks Consensus Estimate by 0.11%. This compares to year-ago revenues of $2.41 billion. The company has topped consensus revenue estimates three times over the last four quarters.

...

https://finance.yahoo.com/news/boston-sc...12034.html

Boston Scientific (BSX) Misses Q1 Earnings, Tightens EPS View

Boston Scientific Corporation BSX posted adjusted earnings per share (EPS) of 35 cents in the first quarter of 2019, up 6.1% from the year-ago quarter. However, the same missed the Zacks Consensus Estimate by a penny. Meanwhile, the figure matched the lower-end of the company’s guided range of 35-36 cents.

Reported EPS in the first quarter was 30 cents compared with earnings of 21 cents per share in the year-ago quarter.

...

https://finance.yahoo.com/news/boston-sc...03149.html

Boston Scientific (BSX) Beats on Q3 Earnings, Tapers EPS View

Boston Scientific Corporation BSX posted adjusted earnings per share (EPS) of 39 cents in the third quarter of 2019, up 11.4% from the year-ago quarter. The same exceeded the Zacks Consensus Estimate by a penny as well. Meanwhile, the figure matched the upper end of the company’s guided range of 37-39 cents.

Reported EPS in the third quarter was 11 cents compared with earnings of 31 cents per share in the year-ago quarter.

Revenues in Detail

Revenues in the third quarter rose 13.1% year over year reportedly, up 14.2% on an operational basis (at constant exchange rate or CER) and up 9.3% on an organic basis (adjusted for foreign currency fluctuations and certain recent acquisitions) to $2.71 billion. Revenues also surpassed the Zacks Consensus Estimate of $2.64 billion by 2.7%.


...

https://finance.yahoo.com/news/boston-sc...01453.html